Digestives & Intestinal Remedies - Worldwide
Worldwide- Revenue in the Digestives & Intestinal Remedies market amounts to US$19.12bn in 2024. The market is expected to grow annually by 2.99% (CAGR 2024-2029).
- In global comparison, most revenue is generated China (US$4bn in 2024).
- In relation to total population figures, per person revenues of US$2.47 are generated in 2024.
Definition:
The Digestives and Intestinal Remedies market comprises over-the-counter natural and synthetic digestive agents and remedies against gastrointestinal complaints. Digestives include preparations in the form of pills, powder, capsules, liquids, solutions, suspensions, drops and suppositories. Not included are prescription medicines, preparations that are against the state law or are not explicit digestive drugs (e.g. painkillers). Among the top-selling digestives are Perenterol, Iberogast, Dulcolax and Buscopan Plus. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.
Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.
In-Scope
- Natural and synthetic agents
- Digestive medicines
- Remedies against gastrointestinal complaints
Out-Of-Scope
- Prescription medicines
- Homeopathic remedies
- Tea
